NCT03353441View on ClinicalTrials.gov

Effects of Microencapsulated Sublingual Glycine (Bidicin) on Cognitive Performance in Healthy Men After an Acute Stressor

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

March 15, 2018

Study Completion Date

June 15, 2018

Conditions
HealthyStress, PsychologicalCognitive Impairment
Interventions
DIETARY_SUPPLEMENT

Microencapsulated Sublingual Glycine (MSG)

Glycine (MSG) tablet

DIETARY_SUPPLEMENT

Placebo

Lactose tablet manufactured to mimic Glycine (MSG) tablet

Trial Locations (1)

54296

daacro GmbH & Co. KG, Trier

All Listed Sponsors
collaborator

OOO MNPK BIOTIKI

UNKNOWN

lead

Daacro

NETWORK

NCT03353441 - Effects of Microencapsulated Sublingual Glycine (Bidicin) on Cognitive Performance in Healthy Men After an Acute Stressor | Biotech Hunter | Biotech Hunter